Form 4: Bio-Rad Laboratories CEO Norman Schwartz Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Norman Schwartz, CEO of Bio-Rad Laboratories, reports a change in his beneficial ownership of company stock due to a gift.
Summary
- On August 26, 2024, Norman Schwartz, the Chairman, President, and CEO of Bio-Rad Laboratories, reported changes in his beneficial ownership of Bio-Rad stock.
- He gifted 57 shares of Bio-Rad B Common Stock.
- Following the transaction, Schwartz directly owns 432,920 shares of Bio-Rad A Common Stock and 361,466 shares of Bio-Rad B Common Stock.
- He also indirectly owns 13,006 shares of Bio-Rad B Common Stock through his spouse and 4,060,054 shares through Blue Raven Partners, L.P.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The change in ownership is unlikely to have a significant impact on stakeholders.
Key Dates
| Date | Description |
|---|---|
| 08/26/2024 | Date of transaction (gift of Bio-Rad B Common Stock) |
| 08/28/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.